68 results on '"Grossman, H."'
Search Results
2. Clinical risk stratification in patients with surgically resectable micropapillary bladder cancer
3. Novel fluorescencein situhybridization-based definition of bacille Calmette-Guérin (BCG) failure for use in enhancing recruitment into clinical trials of intravesical therapies
4. Clinical significance of ureteric ‘skip lesions’ at the time of radical cystectomy: the M.D. Anderson experience and literature review
5. Modeling effects of SGLT‐2 inhibitor dapagliflozin treatment versus standard diabetes therapy on cardiovascular and microvascular outcomes
6. A phase 2 clinical trial of sequential neoadjuvant chemotherapy with ifosfamide, doxorubicin, and gemcitabine followed by cisplatin, gemcitabine, and ifosfamide in locally advanced urothelial cancer
7. Lymph node density for patient counselling about prognosis and for designing clinical trials of adjuvant therapies after radical cystectomy
8. Intake of red meat and heterocyclic amines, metabolic pathway genes and bladder cancer risk
9. Prospective trial to identify optimal bladder cancer surveillance protocol: reducing costs while maximizing sensitivity
10. Do mixed histological features affect survival benefit from neoadjuvant platinum‐based combination chemotherapy in patients with locally advanced bladder cancer? A secondary analysis of Southwest Oncology Group‐Directed Intergroup Study (S8710)
11. High-Frequency Endoluminal Ultrasonography as an Aid to the Staging of Upper Tract Urothelial Carcinoma
12. Incidence of downstaging and complete remission after neoadjuvant chemotherapy for high-risk upper tract transitional cell carcinoma
13. Management of urethral recurrence after orthotopic urinary diversion
14. Quality of pathologic response and surgery correlate with survival for patients with completely resected bladder cancer after neoadjuvant chemotherapy
15. Chemoprevention of bladder cancer
16. Analysis of the expression of biomarkers in urinary bladder cancer using a tissue microarray
17. Genetic variants in cell cycle control pathway confer susceptibility to bladder cancer
18. Neuronal cell adhesion molecule deletion induces a cognitive and behavioral phenotype reflective of impulsivity
19. Dietary isothiocyanates, GSTM1, GSTT1, NAT2 polymorphisms and bladder cancer risk
20. Micropapillary bladder cancer
21. Outcome and patterns of recurrence of nonbilharzial pure squamous cell carcinoma of the bladder
22. Nephroureterectomy for treating upper urinary tract transitional cell carcinoma: time to change the treatment paradigm?
23. Bladder cancer risk as modified by family history and smoking
24. Relevance of extracapsular extension of pelvic lymph node metastasis in patients with bladder cancer treated in the contemporary era
25. Correlation between annual volume of cystectomy, professional staffing, and outcomes
26. Increased plasma levels of angiogenin and the risk of bladder carcinoma
27. Pathologic evaluation of radical cystectomy specimens
28. Methyl-CpG-binding domain 2
29. Specific chromosome aberrations in peripheral blood lymphocytes are associated with risk of bladder cancer
30. Benzo[a]pyrene diol epoxide-induced 9p21 aberrations associated with genetic predisposition to bladder cancer
31. Centrosomal abnormality is common in and a potential biomarker for bladder cancer
32. Urinary nuclear matrix protein 22 (NMP22): A diagnostic adjunct to urine cytologic examination for the detection of recurrent transitional-cell carcinoma of the bladder
33. Human papillomavirus DNA in malignant and hyperplastic prostate tissue of black and white males
34. G-actin as a risk factor and modulatable endpoint for cancer chemoprevention trials
35. Long‐term assessment of renal function following nephrectomy for stage I renal carcinoma
36. Blood group antigens and integrins as biomarkers in head and neck cancer: Is aberrant tyrosine phosphorylation the cause of altered α6β4 integrin expression?
37. Enhanced vasoconstrictor response of the isolated perfused cirrhotic rat liver to humoral vasoconstrictor substances found in portal venous blood
38. Alterations in antigen expression in superficial bladder cancer
39. 18F-2-deoxy-2-fluoro-D-glucose uptake into human tumor xenografts. Feasibility studies for cancer imaging with positron-emission tomography
40. Serum sialic acid is a biologic marker for malignant disease
41. Bladder carcinoma in patients age 40 years or younger
42. Incidental adenocarcinoma of the prostate: The role of repeat transurethral resection in staging
43. Human renal carcinoma: Characterization of five new cell lines
44. Effects of estrogen administration on serum testosterone in copenhagen rats
45. Evaluating Common Intra-Abdominal Masses in Children -- A Systematic Roentgenographic Approach
46. Evaluation of N-acetylneuraminic acid, carcinoembryonic antigen, and alpha-fetoprotein as markers for advanced carcinoma
47. Bladder tumors in two young males occupationally exposed to MBOCA
48. SECONDARY SEX DEVELOPMENT IN MENTALLY DEFICIENT INDIVIDUALS12
49. A SEX - CHROMATIN SURVEY IN MENTALLY DEFECTIVE WOMEN: A METHOD FOR RAPID SCREENING OF POPULATIONS UTILISING DATA PROCESSING METHODS AND NUCLEAR SEXING
50. Wissenschaftliches Repertorium. Aus wissenschaftlichen Vereinen. 78. Versammlung Deutscher Naturforscher und Aerzte in Stuttgart vom 16. bis 22. September 1906
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.